Globe Life Inc. (NYSE:GL) CEO Sells $1,345,410.00 in Stock

Globe Life Inc. (NYSE:GL) CEO Frank M. Svoboda sold 11,000 shares of the business’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $122.31, for a total transaction of $1,345,410.00. Following the sale, the chief executive officer now directly owns 18,948 shares in the company, valued at $2,317,529.88. The trade was a 36.73 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Globe Life Trading Down 1.4 %

NYSE GL opened at $121.80 on Friday. The stock’s 50-day simple moving average is $114.66 and its two-hundred day simple moving average is $108.08. Globe Life Inc. has a twelve month low of $38.95 and a twelve month high of $132.00. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $10.22 billion, a price-to-earnings ratio of 10.19 and a beta of 0.81.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, beating analysts’ consensus estimates of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. Research analysts forecast that Globe Life Inc. will post 13.57 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have issued reports on GL. Jefferies Financial Group boosted their target price on shares of Globe Life from $107.00 to $114.00 and gave the company a “hold” rating in a report on Tuesday, December 10th. Keefe, Bruyette & Woods boosted their target price on shares of Globe Life from $137.00 to $145.00 and gave the company an “outperform” rating in a report on Wednesday. Evercore ISI raised shares of Globe Life from an “in-line” rating to an “outperform” rating and upped their price target for the stock from $132.00 to $143.00 in a report on Wednesday, January 8th. Morgan Stanley upped their price target on shares of Globe Life from $123.00 to $125.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 11th. Finally, Truist Financial upped their price target on shares of Globe Life from $90.00 to $105.00 and gave the stock a “hold” rating in a report on Friday, October 25th. Five investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and an average price target of $133.10.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of GL. Versant Capital Management Inc increased its holdings in shares of Globe Life by 388.0% in the fourth quarter. Versant Capital Management Inc now owns 244 shares of the company’s stock worth $27,000 after buying an additional 194 shares during the period. Albion Financial Group UT purchased a new position in shares of Globe Life in the fourth quarter worth about $28,000. Rakuten Securities Inc. purchased a new position in shares of Globe Life in the fourth quarter worth about $28,000. Riverview Trust Co purchased a new position in shares of Globe Life in the third quarter worth about $32,000. Finally, Avalon Trust Co purchased a new position in shares of Globe Life in the fourth quarter worth about $41,000. Hedge funds and other institutional investors own 81.61% of the company’s stock.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.